LI
IDYA icon

LRI Investments’s IDEAYA Biosciences IDYA Stock Holding History

LRI Investments’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37 Buy
+1
New +$31 ﹤0.01% 1926

Other funds holding IDYA

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

LRI Investments's IDYA Position: Q2 2026 in Review

LRI Investments opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 1 share worth $37. The stake represents ﹤0.01% of the portfolio and ranks #1926 among its holdings.

55 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • LRI Investments held 1 share of IDEAYA Biosciences worth $37 as of Q2 2026.
  • IDEAYA Biosciences was a new LRI Investments position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1926 holding.
  • 55 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.